# A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract

> **NCT01630798** · PHASE1 · COMPLETED · sponsor: **University of Michigan** · enrollment: 60 (actual)

## Conditions studied

- Barrett's Esophagus

## Interventions

- **DRUG:** GI heptapeptide

## Key facts

- **NCT ID:** NCT01630798
- **Lead sponsor:** University of Michigan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-07
- **Primary completion:** 2013-09
- **Final completion:** 2013-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2015-10-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01630798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01630798, "A In-Vivo Esophageal Protocol for Detection of Neoplasia in the Digestive Tract". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01630798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*